| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | CA2299503C Anti-first-pass effect compounds |
| 08/17/2006 | WO2006046135A3 Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/17/2006 | WO2004094647A3 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/16/2006 | EP1690865A1 Porphyrin/phthalocyanine dimer and tetramer directly bonded at pi system and processes for producing these |
| 08/16/2006 | EP1689748A1 Novel 8-(piperazine-1-yl)- and 8-( 1,4|diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 08/16/2006 | EP1689704A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 08/16/2006 | EP1689395A2 Vinca derivatives |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | CA2150805C Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives |
| 08/10/2006 | WO2006083005A1 Fused pyrimidine derivative and used thereof |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1687304A1 Substituted quinolines for the treatment of cancer |
| 08/09/2006 | EP1441737B1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 08/09/2006 | EP1187613B1 Amide substituted imidazoquinolines |
| 08/09/2006 | CN1268630C Synthesis for compound of diamine bridge linking ortho phenanthroline hydrous lanthanum (III) and anti-cancer activity thereof |
| 08/08/2006 | US7087747 μ-Oxo bridged heterometal compound and selective production method thereof |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/02/2006 | EP1685135A1 Tetrahydro-furo¬3,4-d|dioxole compounds and compositions and method for inhibiting platelet aggregation |
| 08/02/2006 | EP1684810A1 Polybiotin compounds for magnetic resonance imagining and drug delivery |
| 08/02/2006 | EP1485389B1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |
| 08/02/2006 | EP1381614B1 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO¬2,3-f|QUINOXALINE |
| 08/02/2006 | CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 08/02/2006 | CN1267434C Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084132 Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
| 08/01/2006 | CA2245823C Farnesyl transferase inhibitors |
| 07/27/2006 | WO2005020894A3 Rifamycin analogs and uses thereof |
| 07/27/2006 | US20060167272 Intermediates for the production of polymethine compounds containing a desired counter ion with high purity and in high yields; improving the solubility in solvents, the compatibility with resins, the durability and the sensitivity to laser beams |
| 07/27/2006 | US20060167033 viral infections; lung tumor and gastric cancer; 7-2-(2-aminophenyldithio)phenyliminomethylcamptothecin |
| 07/27/2006 | US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 07/27/2006 | US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias |
| 07/27/2006 | US20060166977 Antibacterial agents |
| 07/27/2006 | DE112004001860T5 Disulfid-,Sulfid-,Sulfoxid- und Sulfonderivate von cyclischen Zuckern und Verwendungen davon Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof |
| 07/26/2006 | EP1682553A1 Thienopyrazoles |
| 07/26/2006 | EP1682545A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 07/25/2006 | US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction |
| 07/25/2006 | US7081456 N-substitued-4-(3-oxo(thio)chromeno[4,3-c]pyrazol-2(3H)-yl) benzamides or N-substituted-4-(3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl) benzamides; CD80 antigen antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 07/25/2006 | US7081455 sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists |
| 07/25/2006 | CA2242354C Pyrrolopyrimidines and processes for their preparation |
| 07/25/2006 | CA2168921C 1,6-naphthyridonecarboxylic acid derivatives |
| 07/20/2006 | US20060160878 For therapy of central nervous system disorders related to or affected by the 5-HT6 receptor |
| 07/19/2006 | EP1680481A1 New compound capable of being used in organic layer of organic light emitting device |
| 07/19/2006 | EP1680424A2 Heteroaryl fused pyridines, pyrazines and pyrimidines as crf1 receptor ligands |
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | CN1805963A Cannabinoid receptor ligands and uses thereof |
| 07/19/2006 | CN1803792A Phenanthrene/thiophene hybridized high-mobility organic semiconductor and application thereof |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/13/2006 | WO2006072831A1 Pyrrolopyrazoles, potent kinase inhibitors |
| 07/13/2006 | US20060154929 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/12/2006 | EP1678183A1 Spirofuropyridine aryl derivatives |
| 07/12/2006 | CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 07/12/2006 | CN1800189A Method for separating vindoline , catharanthine, vinblastine and vincristine from Vinca rosea |
| 07/12/2006 | CN1799335A Method for improving vinblastine content in madagascar periwinkle |
| 07/12/2006 | CN1263760C Novel buprenorphine ester derivatives and process for preparing the same and medical composition with long-acting analgesic effect |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074792 antiserotonine agents; central nervous system disorders; Alzheimer's disease |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
| 07/11/2006 | CA2246783C Mcbi analogs of cc-1065 and the duocarmycins |
| 07/11/2006 | CA2244256C Antipruritic |
| 07/06/2006 | WO2006052568A3 Tgf-beta inhibitors |
| 07/06/2006 | WO2006017672A3 2, 8-disubstituted naphthyridine derivatives |
| 07/06/2006 | US20060148890 Substituted furochromene compounds of antiinflammatory action |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148831 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/06/2006 | US20060148788 Pyrrolobenzodiazepines |
| 07/06/2006 | US20060148091 Method for determination of absolute configuration of chiral compounds |
| 07/05/2006 | EP1675858A2 5-aryl-pyrazolo [4,3-d] pyrimidines, pyridines, and pyrazines and related compounds |
| 07/05/2006 | CN1798748A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 07/04/2006 | US7071186 Drug abuse; antiserotonine agents; central nervous system disorders; sleep disorders |
| 06/29/2006 | WO2006067614A2 Heteroaromatic derivatives useful as anticancer agents |
| 06/29/2006 | US20060142377 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 06/29/2006 | US20060142330 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's and attention deficit disorder, schizophrenia, obsessive compulsive disorders, |
| 06/29/2006 | US20060142266 Compounds and their uses |
| 06/29/2006 | CA2588220A1 Heteroaromatic derivatives useful as anticancer agents |
| 06/28/2006 | EP1601677B1 Spiro-substituted pyrrolopyrimidines |
| 06/28/2006 | EP1363916A4 Emissive multichromophoric systems |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067511 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
| 06/27/2006 | US7067481 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid |
| 06/22/2006 | WO2006065541A1 Chemical compositions for authenticatable polymers and articles, and authentication methods thereof |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006064517A2 Methods for the purification of 20(s)-camptothecin |
| 06/22/2006 | WO2006044869A8 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 06/22/2006 | US20060135598 citirus-based furocoumarins; for dietary supplements or medicinal foods |
| 06/22/2006 | US20060135546 Methods for the purification of 20(S)- camptothecin |
| 06/22/2006 | US20060135525 Pyrazolopyrimidine compound and a process for preparing the same |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |